Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Clinical trial NCT00884767 · UNKNOWN

Trial details

NCT number: NCT00884767
Sponsor: Institut Cancerologie de l'Ouest
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapeutic Agent Toxicity Colorectal Cancer Neurotoxicity

Start date: 2007-09-01
Primary completion: 2009-08-01
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.